# EDGAR Filing Document

**Accession Number:** 0001089815
**File Stem:** 0001437749-25-019545
**Filing Date:** 2025-6
**Character Count:** 5366
**Document Hash:** ae4c5d0c4369dcb12346b612f5c8dcbb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-019545.hdr.sgml**: 20250605

**ACCESSION NUMBER**: 0001437749-25-019545

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250603

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**FILED AS OF DATE**: 20250605

**DATE AS OF CHANGE**: 20250605

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Elite Health Systems Inc.
- **CENTRAL INDEX KEY:** 0001089815
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 521842411
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-26575
- **FILM NUMBER:** 251027074

**BUSINESS ADDRESS:**
- **STREET 1:** 1131 W 6TH STREET
- **STREET 2:** SUITE 225
- **CITY:** ONTARIO
- **STATE:** CA
- **ZIP:** 91762
- **BUSINESS PHONE:** 949-249-1170

**MAIL ADDRESS:**
- **STREET 1:** 1131 W 6TH STREET
- **STREET 2:** SUITE 225
- **CITY:** ONTARIO
- **STATE:** CA
- **ZIP:** 91762

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Elite Health Systems, Inc.
- **DATE OF NAME CHANGE:** 20241002

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** U.S. NeuroSurgical Holdings, Inc.
- **DATE OF NAME CHANGE:** 20150828

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** US NEUROSURGICAL INC
- **DATE OF NAME CHANGE:** 19990630

?xml version='1.0' encoding='ASCII'? usnu20250604_8k.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): June 3, 2025**

**Elite Health Systems Inc.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **000-26575** | **52-1842411** |
| (State of other jurisdiction of<br> incorporation or organization) | (Commission<br> File Number) | (I.R.S. Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **1131 W 6th Street** |  |
| **Ontario, CA** | **91762** |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code:

**(949) 249-1170**

**Not Applicable**

(Former name, former address and former fiscal year, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐

------

**Item 1.01. Entry onto a Material Agreement.**

On June 3, 2025, Elite Health Plan, Inc. ("Elite Health Plan") a wholly owned subsidiary of Elite Health Systems Inc. (the "Registrant") was notified by the Centers for Medicare and Medicaid Services ("CMS") that it has conditionally approved Elite Health Plan's Contract Year (CY) 2026 Medicare Advantage/Medicare – Prescription Drug (MA-Only/MA-PD) application. To enter into the contract with CMS as an MA/MA-PD organization, CMS must also approve Elite Health Plan's bid, including formulary, as required by 42 CFR 422 Subpart D and 42 CFR 423 Subpart F. Additionally, Elite Health Plan must complete all other required pre-implementation activities, including system and data testing. On June 2, 2025, Elite Health Plan filed the CY 2026 PBP HMO bid submission in partnership with Wakely Consulting Group, an experienced actuarial and consultant in the healthcare industry.

The CMS related regulatory process is complex and there can be no assurance that CMS will ultimately approve Elite Health Plan's bid, or that if approved, that Elite Health Plan will be able to maintain its license under the Act or its approval with CMS.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: June 5, 2025 |  |  |
|  | Elite Health Systems Inc. | Elite Health Systems Inc. |
|  | By: | /s/ Prasad Jeereddi |
|  | Name: | Prasad Jeereddi |
|  | Title: | Chairman and CEO |

---